Eliana Clark, EVP, Chief Technical Officer at Intellia Therapeutics, Inc. (NTLA), sold 607 shares at $13.78 ($8K) on 2026-03-02, disclosed to the SEC on 2026-03-03.
Seasonal sale ($8k) by EVP, Chief Technical Officer — this insider has traded NTLA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| Filing → |
| NTLA | SELL | 2025-03-04 | $6K | — | Filing → |
| NTLA | SELL | 2025-01-06 | $187K | — | Filing → |
| NTLA | SELL | 2024-07-03 | $9K | — | Filing → |